標題: Titlebook: Bronchiectasis; The EMBARC Manual James Chalmers,Eva Polverino,Stefano Aliberti Book 2018 Springer International Publishing AG 2018 Airway [打印本頁] 作者: Hypothesis 時間: 2025-3-21 17:25
書目名稱Bronchiectasis影響因子(影響力)
書目名稱Bronchiectasis影響因子(影響力)學科排名
書目名稱Bronchiectasis網(wǎng)絡(luò)公開度
書目名稱Bronchiectasis網(wǎng)絡(luò)公開度學科排名
書目名稱Bronchiectasis被引頻次
書目名稱Bronchiectasis被引頻次學科排名
書目名稱Bronchiectasis年度引用
書目名稱Bronchiectasis年度引用學科排名
書目名稱Bronchiectasis讀者反饋
書目名稱Bronchiectasis讀者反饋學科排名
作者: sundowning 時間: 2025-3-21 23:54
Imaging of Bronchiectasis,in bronchiectasis assessment, though they suffer from low sensitivity in early phase of disease. Computed tomography (CT) is the current reference standard for noninvasive imaging of bronchial abnormalities. CT offers high-resolution images (<1?mm) with three-dimensional display, which is particular作者: 骯臟 時間: 2025-3-22 01:05 作者: 鎮(zhèn)壓 時間: 2025-3-22 06:29 作者: Flawless 時間: 2025-3-22 12:26 作者: Anhydrous 時間: 2025-3-22 13:56
How to Identify Causes and Predisposing Factors in Bronchiectasis,ction and recurrent respiratory infections leading to an increased morbidity and impaired patients’ quality of life [1]. Both prevalence and incidence of bronchiectasis have not been defined yet, although recent literature reports an increase of hospitalisations due to this disease [2]. The few exis作者: 先兆 時間: 2025-3-22 17:09 作者: surmount 時間: 2025-3-22 22:18
Chronic Rhinosinusitis and Bronchiectasis,, in many occasions, of a multidisciplinary work. In recent years it has been demonstrated that bronchopulmonary pathologies are usually associated with nasosinusal pathology, thus creating the concept of rhinobronchitis and “one airway, one disease.” There are few studies that correlate bronchiecta作者: stress-response 時間: 2025-3-23 02:56
COPD and Bronchiectasis,hare a similar clinical-functional picture, and this often leads to mistaken diagnoses [3]; they also share a similar inflammatory profile, dominated by neutrophils [4]. Nevertheless, the two diseases are fundamentally different in terms of their prognosis and therapeutic management [5, 6]. Over and作者: palpitate 時間: 2025-3-23 07:13
Other Predisposing Factors for Bronchiectasis,onchi, and clinically, by persistent cough, sputum production, recurrent respiratory tract infections and general malaise [1]. Data across multiple healthcare systems suggest that the prevalence of bronchiectasis is increasing [2–4]. Whether this represents a real increase in disease burden, perhaps作者: 駁船 時間: 2025-3-23 13:23
Severity of the Disease, Site of Care and Self-Management,ions and a detrimental impact on quality of life. The cornerstone of bronchiectasis is abnormal dilation of the bronchi and this is visible on CT scanning of the thorax; however radiological assessment of bronchiectasis is not encompassing enough to fully assess severity [1]. There are patients with作者: vasospasm 時間: 2025-3-23 14:44
, and Bronchiectasis,s chapter, we highlight important aspects of . biology, its virulence factors and the multiple routes to antibiotic resistance including biofilm and genetic mechanisms. We also highlight clinical challenges in managing patients with persistent infection.作者: 小卷發(fā) 時間: 2025-3-23 21:59
The Role of Other Bacteria, Fungi, and Viruses in Bronchiectasis, the airways and the surrounding lung parenchyma [1]. Many microorganisms have been associated with bronchiectasis, both as a complication of the anatomic abnormalities and possibly as a cause of the structural disease as well [2, 3]. Diverse polymicrobial communities are present in the airways of p作者: 有罪 時間: 2025-3-23 22:44
NTM in Bronchiectasis,th an increase in incidence and prevalence worldwide [1, 2]. While . (MAC) remains the most common of the NTM isolates causing lung disease throughout the world, there are geographic variations of other NTM species-specific lung disease differences at the inter- and intracontinental levels that are 作者: 邊緣帶來墨水 時間: 2025-3-24 06:25 作者: BUOY 時間: 2025-3-24 06:57 作者: 使長胖 時間: 2025-3-24 14:30
Airway Clearance in Bronchiectasis,e aims of ACT and current practices in bronchiectasis. The main physiological mechanisms underlying ACTs as well as the current evidence base are detailed. Mucoactive drugs are discussed particularly in terms of dose, delivery device/route and timing with ACT to facilitate airway clearance. Recognis作者: dendrites 時間: 2025-3-24 15:22 作者: 咆哮 時間: 2025-3-24 19:35
How to Identify Causes and Predisposing Factors in Bronchiectasis,ting European data show a prevalence of bronchiectasis from 67 to 566 . 100,000, while prevalence in the USA has been estimated about 52 . 100,000 [3–6]. All these data have changed the earlier consideration of bronchiectasis as an orphan disease towards an increased awareness of this condition.作者: 無法解釋 時間: 2025-3-24 23:18 作者: 借喻 時間: 2025-3-25 06:21 作者: 縱欲 時間: 2025-3-25 08:00 作者: ALE 時間: 2025-3-25 15:12 作者: alcoholism 時間: 2025-3-25 18:00 作者: obeisance 時間: 2025-3-25 20:00
Book 2018 especially on diagnosis and existing and emerging therapies, but the book also covers a wide range of other key topics, from pathophysiology, histopathology, and immunology through to pulmonary rehabilitation, nursing care, and management in primary care and pediatric settings. .While non–cystic fi作者: 初學者 時間: 2025-3-26 03:58
asis.This book presents state of the art knowledge and practice in the rapidly developing field of bronchiectasis not due to cystic fibrosis. The focus is especially on diagnosis and existing and emerging therapies, but the book also covers a wide range of other key topics, from pathophysiology, his作者: 賠償 時間: 2025-3-26 06:25 作者: 憤怒歷史 時間: 2025-3-26 10:40 作者: 保留 時間: 2025-3-26 14:26 作者: AROMA 時間: 2025-3-26 19:05 作者: 救護車 時間: 2025-3-26 22:12
https://doi.org/10.1007/978-3-663-10743-9ectasis in immune-deficient patients including recommendations on immunisation, antibiotic prophylaxis, immunoglobulin replacement therapy, joint respiratory-immunology care clinics and long-term monitoring.作者: 音樂學者 時間: 2025-3-27 05:06 作者: 沉默 時間: 2025-3-27 07:16
Immunodeficiency in Bronchiectasis,ectasis in immune-deficient patients including recommendations on immunisation, antibiotic prophylaxis, immunoglobulin replacement therapy, joint respiratory-immunology care clinics and long-term monitoring.作者: 爆炸 時間: 2025-3-27 10:18 作者: 起來了 時間: 2025-3-27 15:23
Imaging of Bronchiectasis,ogical descriptors for specific diagnosis in a number of cases. Radiological scores by HRCT are complementary in the management of bronchiectasis; the integration with clinical parameters is mandatory to define the disease activity.作者: headlong 時間: 2025-3-27 18:12
Epidemiology,ry problems are the most common cause of death. The presence of bronchiectasis can have implications in the prognosis of other diseases. The incremental direct costs of bronchiectasis are significant. Indirect cost data (e.g., due to absenteeism from work) are lacking, clearly underestimating the ec作者: Metamorphosis 時間: 2025-3-28 00:13 作者: 取回 時間: 2025-3-28 02:16
Pathophysiology, Immunology, and Histopathology of Bronchiectasis,biological analysis has contributed to better understanding of the role of microbiome in the pathogenesis and evolution of the disease. In this chapter, we review and discuss evidence and new insights into the pathophysiology, immunology, and histopathology of bronchiectasis.作者: Arbitrary 時間: 2025-3-28 07:29 作者: 燒烤 時間: 2025-3-28 11:59 作者: Ankylo- 時間: 2025-3-28 15:19
The Role of Other Bacteria, Fungi, and Viruses in Bronchiectasis,blematic pathogen in patients with bronchiectasis and is associated with a worse prognosis [7, 8]. Multiple epidemiologic reports have shown that approximately 20–35% of patients worldwide with bronchiectasis are chronically infected with . [2, 9, 10]. Several antibiotic trials have been published w作者: Lacunar-Stroke 時間: 2025-3-28 21:37
NTM in Bronchiectasis, rates of NTM lung disease appear to qualitatively parallel environmental NTM [7]. That is to say, despite the ubiquitous nature of NTM in the environment, geographic areas with increased NTM present appear to be associated with increased prevalence of NTM lung disease [4]. Complex relationships are作者: Binge-Drinking 時間: 2025-3-28 23:30
Long-Term Inhaled Antibiotic Treatment in Bronchiectasis,mulations and nebuliser systems, as well as ensuring adherence with complex treatment regimens. Future studies may provide additional evidence of benefit and finally result in licenced indications for inhaled antibiotics in people with bronchiectasis.作者: 鴕鳥 時間: 2025-3-29 03:43
https://doi.org/10.1007/978-3-662-12422-2ogical descriptors for specific diagnosis in a number of cases. Radiological scores by HRCT are complementary in the management of bronchiectasis; the integration with clinical parameters is mandatory to define the disease activity.作者: negligence 時間: 2025-3-29 09:46 作者: Nonthreatening 時間: 2025-3-29 11:23
https://doi.org/10.1007/978-3-663-10743-9ptoms include daily sputum production, dyspnoea and chest pain (Table 4.1). The frequency and severity of symptoms are often related to the extent of the bronchiectasis and the coexistence with other respiratory or systemic diseases [5]. Sputum production may be affected by recurrent infections, the作者: 不在灌木叢中 時間: 2025-3-29 18:43 作者: Limited 時間: 2025-3-29 22:42
Klaus Backhaus,Bernd Günter,Hans Rafféea greater pulmonary involvement on CT compared with those without CRS. This finding suggests that CRS is a marker of activity in BQs patients..Guilemany et al. were the first to assess the effect on general quality of life (QoL) in patients with BQs and CSR using the SF-36 test showing that in all d作者: 壓倒性勝利 時間: 2025-3-30 00:32
,Zusammenfassung und Schlu?bemerkungen,emonstrated any causal relationship between the two diseases. Furthermore, it has been noted that patients with alpha-1 antitrypsin deficiency (a rare form of COPD characterized by the presence of panacinar emphysema, typically found in smokers), presents a high prevalence of bronchiectasis [11, 12]作者: 兩種語言 時間: 2025-3-30 07:09 作者: conscribe 時間: 2025-3-30 08:13 作者: nominal 時間: 2025-3-30 15:53
Die Herausforderungen des (50plus-)Marktes,mulations and nebuliser systems, as well as ensuring adherence with complex treatment regimens. Future studies may provide additional evidence of benefit and finally result in licenced indications for inhaled antibiotics in people with bronchiectasis.作者: Estrogen 時間: 2025-3-30 16:37
Book 2018erest to respiratory, internal medicine, and infectious disease fellows as well as specialists, final-year medical students, nurses and physiotherapists. The authors are leading experts and chairs of the steering committee of EMBARC, the first truly international bronchiectasis network.?.作者: glomeruli 時間: 2025-3-30 22:59 作者: 壯麗的去 時間: 2025-3-31 02:50
James Chalmers,Eva Polverino,Stefano AlibertiCovers all aspects of bronchiectasis.Presents the state of the art in diagnosis and treatment.Written by international experts on bronchiectasis作者: Density 時間: 2025-3-31 06:51 作者: generic 時間: 2025-3-31 10:12 作者: 排斥 時間: 2025-3-31 14:24 作者: exceptional 時間: 2025-3-31 18:22
Die Auswirkungen einer CO2-Steuer,n is necessary for its diagnosis. The incidence of cystic fibrosis is 1:2000–3500 live births in northern Europe and North America. Epidemiological data show an increase in the incidence and prevalence of bronchiectasis, as well as an increase in hospital admissions and mortality in the last two dec作者: 漫步 時間: 2025-4-1 01:40 作者: 吹氣 時間: 2025-4-1 02:35
https://doi.org/10.1007/978-3-663-10743-9rreversible bronchial dilatation due to diverse etiologies. Several factors have been related to a vicious cycle that perpetuates airway inflammation and increases the risk of bronchial infections, including various immunological disorders. Increased recruitment and migration of neutrophils to airwa作者: 鳴叫 時間: 2025-4-1 09:30
